Title
Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer
Date Issued
01 December 2020
Access level
open access
Resource Type
review
Author(s)
Khan K.
Javed Z.
Iqbal M.J.
Sadia H.
Raza S.
Irshad A.
Salehi B.
Reiner Ž.
Sharifi-Rad J.
Universidad Arturo Prat
Publisher(s)
BioMed Central Ltd
Abstract
Bladder cancer (BC) is a leading cause of death among urothelial malignancies that more commonly affect male population. Poor prognosis and resistance to chemotherapy are the two most important characteristics of this disease. PI3K/Akt/mTOR signaling pathway has been considered pivotal in the regulation of proliferation, migration, invasiveness, and metastasis. Deregulation of PI3K/Akt/mTOR signaling has been found in 40% of bladder cancers. Several microRNAs (miRNAs) have been reported to interact with the PI3K/Akt/mTOR signaling pathway with a different possible role in proliferation and apoptosis in bladder cancer. Thus, miRNAs can be used as potential biomarkers for BC. Natural compounds have been in the spotlight for the past decade due to their effective anti-proliferative capabilities. However, little is known of its possible effects in bladder cancer. The aim of this review is to discuss the interplay between PI3K/Akt/mTOR, miRNAs, and natural compounds and emphasize the importance of miRNAs as biomarkers and resveratrol, curcumin and paclitaxel as a possible therapeutic approach against bladder cancer.
Volume
20
Issue
1
Language
English
OCDE Knowledge area
Farmacología, Farmacia
Oncología
Subjects
Scopus EID
2-s2.0-85096436150
Source
Cancer Cell International
ISSN of the container
14752867
Sources of information:
Directorio de Producción Científica
Scopus